UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIG
676
DELISTED
Big Lots, Inc.
BIG
| $20.2M | 0.02% |
449,739
+131,898
| +41% | +$6.14M |
|
677
Regency Centers
REG
$14.5B
| $20.2M | 0.02% |
342,520
+3,266
| +1% | +$209K |
|
678
ManpowerGroup
MAN
$2.49B
| $20.2M | 0.02% |
225,811
-842
| -0.4% | -$72.6K |
|
679
Alliant Energy
LNT
$18.3B
| $20.1M | 0.02% |
697,172
+2,536
| +0.4% | +$76.9K |
|
|
ETFC
680
DELISTED
E*Trade Financial Corporation
ETFC
| $20M | 0.02% |
667,202
+296,819
| +80% | +$8.72M |
|
681
Flex
FLEX
$46.5B
| $20M | 0.02% |
2,343,743
-186,201
| -7% | -$1.71M |
|
682
MGM Resorts International
MGM
$11.6B
| $19.7M | 0.02% |
1,078,310
+26,854
| +3% | +$545K |
|
683
DexCom
DXCM
$32.9B
| $19.6M | 0.02% |
982,764
+35,480
| +4% | +$623K |
|
|
ADT
684
DELISTED
ADT Corp
ADT
| $19.6M | 0.02% |
584,528
-624
| -0.1% | -$23.8K |
|
685
Lincoln Electric
LECO
$14.9B
| $19.6M | 0.02% |
321,985
+70,085
| +28% | +$4.64M |
|
|
PDCO
686
DELISTED
Patterson Companies, Inc.
PDCO
| $19.5M | 0.02% |
401,156
-43,847
| -10% | -$2.09M |
|
687
IPG Photonics
IPGP
$3.82B
| $19.4M | 0.02% |
227,763
-47,008
| -17% | -$4.42M |
|
688
Trip.com Group
TCOM
$29.4B
| $19.3M | 0.02% |
530,800
-131,200
| -20% | -$4.58M |
|
|
TMH
689
DELISTED
Team Health Holdings Inc
TMH
| $19.3M | 0.02% |
294,845
+2,119
| +0.7% | +$128K |
|
|
KERX
690
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $19.3M | 0.02% |
1,930,099
+82,603
| +4% | +$886K |
|
|
PFPT
691
DELISTED
Proofpoint, Inc.
PFPT
| $19.3M | 0.02% |
302,493
-194
| -0.1% | -$11.4K |
|
692
Quanta Services
PWR
$105B
| $19.2M | 0.02% |
665,223
-1,503
| -0.2% | -$43.9K |
|
693
News Corp Class A
NWSA
$15.2B
| $19.1M | 0.02% |
1,312,077
-271,967
| -17% | -$4.18M |
|
694
AGCO
AGCO
$7.41B
| $19.1M | 0.02% |
335,751
+15,951
| +5% | +$810K |
|
|
WLL
695
DELISTED
Whiting Petroleum Corporation
WLL
| $19.1M | 0.02% |
1,890
-182
| -9% | -$1.9M |
|
|
SPLK
696
DELISTED
Splunk Inc
SPLK
| $19M | 0.02% |
273,437
+204,662
| +298% | +$13.8M |
|
697
Gartner
IT
$11.7B
| $18.8M | 0.02% |
219,693
+162,320
| +283% | +$13.9M |
|
|
HTWR
698
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $18.7M | 0.02% |
256,611
+48,045
| +23% | +$3.75M |
|
|
CBPO
699
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $18.6M | 0.02% |
+161,629
| New | +$17M |
|
700
SM Energy
SM
$7.58B
| $18.5M | 0.02% |
400,466
-4,766
| -1% | -$251K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.